Mechanism of oral tolerance induction to therapeutic proteins - Test2 - elhamkhani - TriplyDB

Mechanism of oral tolerance induction to therapeutic proteins

Mechanism of oral tolerance induction to therapeutic proteins

http://www.wikidata.org/entity/Q26866369

about

Targeted approaches to induce immune tolerance for Pompe disease therapy Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease Plant-made oral vaccines against human infectious diseases-Are we there yet?Plastid genomics in horticultural species: importance and applications for plant population genetics, evolution, and biotechnology Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells Gene therapy for hemophilia Oral tolerance to cancer can be abrogated by T regulatory cell inhibition Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human Diseases Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells T cells in the control of organ-specific autoimmunity Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice.Oral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice.Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector.Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4(+) T Cells.Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.In vivo induction of regulatory T cells for immune tolerance in hemophilia.Edible plants for oral delivery of biopharmaceuticals.Innovating immune tolerance induction for haemophilia.Complexity of immune responses to AAV transgene products - Example of factor IX.An overview on the role of silica-based materials in vaccine development.Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce.Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice.Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A.Gene Therapy With Regulatory T Cells: A Beneficial Alliance.Preexisting antigen-specific immune responses are modulated by oral KLH feeding in humans.Histological and immunological characteristics of the junctional epithelium.

P2860

Q26767363-868F71C8-F632-4988-9832-03A6078BBD19 Q26768500-77FFD07D-44B5-4CAA-9844-04C90498ECA6 Q26783111-F90F6022-F19D-4F0B-AF31-6C511C140277 Q26797305-04717F47-DE26-4128-9CC8-3D1A576DDDE5 Q28079063-1BD32249-64FE-43B2-99FA-D077589D37BC Q28081911-BBDAA198-433C-484F-BBD8-8AC3A2F991F6 Q33618271-E23633BC-BA66-489A-8FC6-CD160769BDF8 Q33870122-74D053F1-F27C-4F02-852C-AC5884BD9D71 Q34137024-DEA48EC9-D113-486B-AA28-50418FEBD891 Q35348677-52EF9543-4292-48BD-935F-CD9DAC57E32B Q35836118-90E1AD0D-FC5C-4D21-94A6-3796AC09B613 Q35897441-3931D68E-370D-4CFF-91F9-90BF80747072 Q36083396-68C2FFDD-8A87-4DA3-9054-73FEA326973E Q36252781-2CDA2DDF-2D88-4D36-91CC-C69D42142821 Q36582796-97FBA8FF-2F59-4246-B731-C18FAA2687D4 Q37541716-6CD605EF-CDB3-4627-884A-D3FED21D3039 Q37620814-19C54FA3-0C74-4DBC-A771-7353FB9E3C45 Q37638227-F304C0FF-70C0-4450-8C58-298058D26F29 Q37836218-A104FA62-53E4-40ED-9E35-546B3C170ED8 Q38574966-53CB8C6E-43FB-4BEC-B5DB-47C1A42BF6AC Q38796221-4D276371-C62F-448D-A492-06F1E9522915 Q38894155-EAB909D1-8D82-461A-87DA-33BE183EE18C Q39394803-42B3575D-791F-4EE8-A234-30F86F8D70A4 Q39781727-842F9E6F-62F9-4B37-A3A1-F4088F4110E4 Q45864205-5D830DEF-7ADC-4196-97FD-8B9B8E57F286 Q45874015-278059BC-1497-4FF0-B44D-16CC248D38FB Q45875675-1D3AEDA2-7F6A-4637-85EB-3BA997081D3F Q52721830-0814F51C-5316-45E8-9407-047933A7DD5D Q52867911-3489F367-4103-45DE-81FF-8FC9487AE609 Q55479756-4127D26C-F625-4145-8054-A70996E95E0D

P2860

Mechanism of oral tolerance induction to therapeutic proteins

http://www.wikidata.org/entity/Q26866369

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Mechanism of oral tolerance induction to therapeutic proteins

@ast

Mechanism of oral tolerance induction to therapeutic proteins

@en

Mechanism of oral tolerance induction to therapeutic proteins

@nl

type

label

Mechanism of oral tolerance induction to therapeutic proteins

@ast

Mechanism of oral tolerance induction to therapeutic proteins

@en

Mechanism of oral tolerance induction to therapeutic proteins

@nl

prefLabel

Mechanism of oral tolerance induction to therapeutic proteins

@ast

Mechanism of oral tolerance induction to therapeutic proteins

@en

Mechanism of oral tolerance induction to therapeutic proteins

@nl

P1433

Q26866369-1C70883C-F657-4FCD-828E-CACA5D3BA8CE

P1476

Q26866369-B6D9F2F7-2B95-4E6A-8A64-8B6490976CCA

P2093

Q26866369-01E49AA6-5A9D-4AB5-B1BC-615D8FB23969

Q26866369-34FD1F50-13F6-4AB3-82CC-EAB162A35233

Q26866369-3D4C4513-BF35-4D0F-BAFB-CD36A8490347

Q26866369-5CE58026-8D1B-4BAF-9F35-B10A66060A67

Q26866369-865F1466-1F6F-4D0D-8F44-533784D82DC3

Q26866369-A2AED2E2-D043-48AC-BA8E-2A618C7D1000

Q26866369-A7038217-E6A1-4F0F-87C4-3CD90D0636D4

P2860

Q26866369-004FA7F4-AE05-4E93-99CF-59BEF137B170

Q26866369-006D89A4-9C24-434F-A4F2-159C872E97EF

Q26866369-01E2EA2F-CB93-4377-ACFE-C6AE6B5CC7B3

Q26866369-062B6DC6-53AA-4738-B5A2-E8EB5CA2459B

Q26866369-064B9357-BAA5-486C-BE9B-7550FCF3BE76

Q26866369-0720BE15-9C46-408B-9616-BE779B89BCFC

Q26866369-07F15CB1-8636-404A-ADDF-09D0C3BF65D5

Q26866369-0825C63C-0B3B-4E4F-BDC3-965076FB8AEE

Q26866369-0ADB4782-ED27-4657-AD0D-8A4A7230CE63

Q26866369-0B17C516-F728-4862-9F5F-2872C471F806

P304

Q26866369-3BB816EB-29A9-4553-9699-9653B7A4FD7C

P31

Q26866369-1657B9E0-C034-43AC-83F9-5B8F854CB196

P3181

Q26866369-4BCFA9F1-DA45-429A-A2E9-D517A64350D6

P356

Q26866369-CF796E83-C939-4E17-A746-1E2F3DA46832

P407

Q26866369-0669E8E6-83FF-4ECF-99C9-6ECD2F519033

P433

Q26866369-70B24019-3A1C-4471-8E02-35714025CBFF

P478

Q26866369-14D1A9FE-1606-41BA-9A7C-26A2115452A7

P577

Q26866369-3B7823EA-BDA7-43F0-9E0C-0190589581EC

P5875

Q26866369-30C8F2AA-0F53-4E99-B73F-4712A4B66457

P698

Q26866369-13ED9446-0153-4F3A-8C03-1657743EF9BA

P932

Q26866369-834E5CD4-5B18-4402-AD7F-49DCA8C55EEC

P3181

P356

J.ADDR.2012.10.013

P1433

Advanced Drug Delivery Reviews

P1476

Mechanism of oral tolerance induction to therapeutic proteins

@en

P2093

Alexandra Sherman

http://www.w3.org/2001/XMLSchema#string

Cox Terhorst

http://www.w3.org/2001/XMLSchema#string

Gongxian Liao

http://www.w3.org/2001/XMLSchema#string

Henry Daniell

http://www.w3.org/2001/XMLSchema#string

Kam W. Leong

http://www.w3.org/2001/XMLSchema#string

Roland W. Herzog

http://www.w3.org/2001/XMLSchema#string

Xiaomei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function

Foxp3 occupancy and regulation of key target genes during T-cell stimulation

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

TGF-beta: a mobile purveyor of immune privilege

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

P304

759-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4641479

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.ADDR.2012.10.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232811915

http://www.w3.org/2001/XMLSchema#string

P698

23123293

http://www.w3.org/2001/XMLSchema#string

P932

3578149

http://www.w3.org/2001/XMLSchema#string